SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-018898
Filing Date
2024-05-13
Accepted
2024-05-13 16:25:00
Documents
18
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48948
2 ex99-1.htm EX-99.1 96816
3 ex99-2.htm EX-99.2 112703
4 ex99-1_001.jpg GRAPHIC 11020
5 ex99-2_001.jpg GRAPHIC 11020
  Complete submission text file 0001493152-24-018898.txt   545452

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE harrowcom-20240513.xsd EX-101.SCH 3979
7 XBRL DEFINITION FILE harrowcom-20240513_def.xml EX-101.DEF 27027
8 XBRL LABEL FILE harrowcom-20240513_lab.xml EX-101.LAB 37273
9 XBRL PRESENTATION FILE harrowcom-20240513_pre.xml EX-101.PRE 25647
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6677
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 24939436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)